Avation Medical

About Avation Medical

Avation Medical focuses on providing innovative at-home treatment solutions for Overactive Bladder (OAB) with their FDA-cleared Vivally(r) System, aiming to inspire confidence, freedom, and improved quality of life for OAB patients.

Products & Services

Vivally(r) System:An FDA-cleared wearable at-home treatment for Overactive Bladder (OAB) symptoms, including incontinence and urgency. It involves a 30-minute session three times a week using the Vivally Wrap, CliQ device for symptom control, and a mobile app for tracking progress and patient support.

Specialties

Wearable Medical Devices Neuromodulation Overactive Bladder Treatment Digital Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 22000000 MR: - FA: more than $22 million FAN: 22000000	D: 2024-02-01 FD: 2024-02-01	8 investors

Series C Latest

2024-02-01

$22.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jason Whiting

Chief Executive Officer and Member of the Board

M

Mike Gill

Chief Commercial Officer

M

Manish Vaishya

Chief Technology Officer, Co-Founder, PhD, MBA

J

Jackie Gerberry

Vice President Finance and Human Resources, CPA, MBA

M

Michael Hoffman

Vice President of Market Access and Payer Relations

T

Tom Shehab

Chairman of the Board

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Avation Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised